The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Medicis has no obligation to update any information contained in such press releases after the date of their issuance. For current information about the Company, please refer to our most recent public filings with the Securities and Exchange Commission.

Note that in November 2008 the Company restated its financial statements for the annual, transition and quarterly periods in fiscal years 2003 through 2007 and the first and second quarters of 2008, and, accordingly, filed an amended annual report on Form 10-K/A for the year ended December 31, 2007, and amended quarterly reports on Forms 10-Q/A for the quarters ended March 31, 2008, and June 30, 2008. Readers are cautioned to refer to the SEC filings associated with the Company's restatement for correct financial data.

Receive all Medicis press releases via email

View the Medicis Press Release Archive

2004 Press Releases
Keyword Search:  
Dec 30, 2004
Medicis to Present at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Dec 14, 2004
Medicis Licenses Proprietary Peptide Technology from Ansata Therapeutics
Dec 14, 2004
Medicis Declares Cash Dividend
Nov 3, 2004
Medicis to Present at CIBC World Markets 15th Annual Healthcare Conference
Oct 29, 2004
Company Profile for Medicis
Oct 19, 2004
Medicis Reports First Quarter Fiscal 2005 Financial Results
Oct 19, 2004
Restylane Honored with Allure Magazine's 'Best of Beauty' Breakthrough Award
Oct 14, 2004
Medicis Announces First Quarter Fiscal 2005 Conference Call and Webcast
Sep 23, 2004
Medicis to Present at UBS Global Life Sciences Conference
Sep 14, 2004
Medicis Declares Cash Dividend
Sep 2, 2004
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds 2004 Conference
Aug 24, 2004
Medicis Reports Fourth Quarter and Year-End Fiscal 2004 Financial Results
Aug 19, 2004
Medicis Announces Fiscal 2004 Fourth Quarter and Year-End Conference Call and Webcast
Jul 15, 2004
Medicis Licenses SubQ from Q-Med
Jun 21, 2004
Medicis Announces Fiscal 2005 Guidance
Jun 18, 2004
Medicis to Present at Wachovia Securities Equity Conference
Jun 10, 2004
Medicis Declares Cash Dividend
Jun 9, 2004
Medicis to Present at Thomas Weisel Partners Growth Forum 6.0
Jun 1, 2004
Complaint Against Medicis Filed by Inamed
May 19, 2004
Medicis to Present at UBS Global Specialty Pharmaceuticals Conference
May 18, 2004
Medicis Closes License of ORAPRED to BioMarin with Option to Purchase
May 3, 2004
Medicis to Present at Smith Barney Citigroup Small & Mid-Cap Conference
Apr 29, 2004
Medicis Reports Third Quarter Fiscal 2004 Financial Results
Apr 28, 2004
Medicis to Present at Deutsche Bank Securities 29th Annual Health Care Conference
Apr 20, 2004
Medicis Licenses ORAPRED to BioMarin With Option to Purchase
Apr 14, 2004
Medicis Announces Third Quarter Fiscal 2004 Conference Call and Webcast
Mar 16, 2004
Medicis Declares Cash Dividend
Feb 19, 2004
Medicis to Present at Smith Barney 4th Annual Specialty Pharmaceuticals Conference
Feb 2, 2004
Medicis to Present at 2004 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Jan 22, 2004
Medicis Reports Second Quarter Fiscal 2004 Financial Results
Jan 16, 2004
Medicis Announces Second Quarter Fiscal 2004 Conference Call and Webcast
Jan 8, 2004
Medicis to Present at 22nd Annual J.P. Morgan Healthcare Conference
Jan 6, 2004
Medicis Announces First Shipment of RESTYLANE to Physicians
Jan 2, 2004
Medicis Announces 2 for 1 Stock Split


© 1996-2010 Medicis Pharmaceutical Corp